CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 92 enrolled
Drug / intervention
Myopia control lensother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05250206
NCT05250206N/ACompleted
CompareCT.gov

Evaluation of Ophthalmic Lenses for Myopia Management

Indizen Optical Technologies, S.L.U.·interventional·Posted Feb 22, 2022·Updated Jun 10, 2025

In Brief

A clinical study evaluating Myopia control lens for Myopia. Completed, enrolled 92 participants across 1 site.

Detailed Summary

Evaluation of the efficacy in decreasing myopia progression of the proposed ophthalmic lens prototypes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesSpain
CollaboratorsUniversidad Europea de Madrid

Timeline

N/ACompletedFinished
20222023202420252026
First PostedFeb 22, 2022
Enrollment StartJun 7, 2021
Primary CompletionNov 30, 2024
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 4.4 years ago

Interventions

Myopia control lensother

Evaluation of the efficacy in decreasing myopia progression of the proposed ophthalmic lens prototypes.